|
| | Issue Date | Title | Author(s) |
| 101 | 18-Sep-2015 | Molecular design and synthesis of certain new quinoline derivatives having potential anticancer activity | Ibrahim, Diaa A; Abou El Ella, Dalal ; El-Motwally, Amira M; Aly, Rasha M |
| 102 | Oct-2013 | Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold | Al-Ansary, Ghada H; Ismail, Mohamed A H; Abou El Ella, Dalal ; Eid, Sameh; Abouzid, Khaled |
| 103 | Dec-2022 | Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells | Abdelhafiz, Abeer H A; Serya, Rabah A T; Lasheen, Deena S. ; Wang, Nessa; Sobeh, Mansour; Wink, Michael; Abouzid, Khaled |
| 104 | Mar-2013 | Molecular design, synthesis and cell based HCV replicon assay of novel benzoxazole derivatives | Ismail, M A H; Сиддик Адель Мухаммед ; Ismail, N S M; Abouzid, Khaled |
| 105 | Dec-2021 | Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine-hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer | Abdel-Atty, Mona M; Farag, Nahla A; Serya, Rabah A T; Abouzid, Khaled ; Mowafy, Samar |
| 106 | 2009 | Molecular Modeling Design, Synthesis and Biological Evaluation of New Imidazoline Derivatives Linked as α1-AR Antagonists and Ang II Receptor Antagonists | Mohamed A. H. Ismail; Abou El Ella, Dalal ; Khaled A. M. Abouzid; Deena S. M. Lasheen |
| 107 | 2015 | Molecular modeling design, synthesis, and anti-hyprglycemic evaluation of certain 5-(aryl-alkoxy-benzylidine)-imidazolidine-2,4-dione derivatives as potential PPAR gamma agonists | Ismail, MAH; Abouzid, Khaled ; Abdou, NS; Lahham, A; Abou El Ella, Dalal |
| 108 | 1-Mar-2008 | Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities | Abou El Ella, Dalal ; Ghorab, Mostafa M.; Noaman, Eman; Heiba, Helmy I.; Khalil, Amira I. |
| 109 | Feb-2011 | Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists | Abou-Seri, Sahar Mahmoud; Abouzid, Khaled ; Abou El Ella, Dalal |
| 110 | 2014 | Molecular modelling and synthesis of quinazoline-based compounds as potential antiproliferative agents | Yassen, Asmaa Said Ali; Elshihawy, Hosam Eldin Abd Elhamed Ahmed; Said, Mohamed Mokhtar Amin; Abouzid, Khaled |
| 111 | 2014 | Naphthalene and 2,3-dihydrobenzo[b][1,4]dioxine derivatives with extended side chains as new scaffolds of CB2-selective ligands | Osman, Noha A.; Mahmoud, Amr H.; Klein, Christian D.; Allarà, Marco; Di Marzo, Vincenzo; Khaled A M Abouzid ; Abadi, Ashraf H. |
| 112 | Oct-2022 | New fluorinated diarylureas linked to pyrrolo[2,3-d]pyrimidine scaffold as VEGFR-2 inhibitors: Molecular docking and biological evaluation | Adel, Mai; Abouzid, Khaled |
| 113 | Dec-2007 | A NEW SCAFFOLD FOR D3 DOPAMINERGIC AFFINITY CONTAINING ARYLPIPERAZINE FRAGMENT: MOLECULAR MODELING, SYNTHESIS, IN VITRO AND IN VIVO PHARMACOLOGICAL EVALUATION | Abou El Ella, Dalal ; Franziska K. U. Müller |
| 114 | Dec-2022 | Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2 | Shaker, Ahmed M M; Shahin, Mai I. ; AboulMagd, Asmaa M; Abdel Aleem, Seham A; Abdel-Rahman, Hamdy M; Abou El Ella, Dalal |
| 115 | 2013 | Novel 2-thiopyrimidine derivatives as CDK2 inhibitors: molecular modeling, synthesis, and anti-tumor activity evaluation | Fathalla, OAM; Ismail, MAH; Anwar, MM; Abouzid, Khaled ; Ramadan, AAK |
| 116 | 15-May-2008 | Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity | Abouzid, Khaled ; Bekhit, Salma A |
| 117 | 2020 | Novel Benzimidazole/Hydrazone Derivatives as Promising Anticancer Lead Compounds: Design, Synthesis, and Molecular Docking Study | Morcoss, Martha; Abdelhafez, El Shimaa; Abdel-Rahman, Hamdy; lhab Abdel Aziz Mohammed ; Abou El Ella, Dalal |
| 118 | 1-Dec-2017 | Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity | Aly, Rasha M.; Serya, Rabah ; El-Motwally, Amira M.; Abbas, Safinaz; Abou El Ella, Dalal ; Esmat, Ahmed |
| 119 | 15-Jul-2018 | Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells | Ismail, Rania S M; Abou-Seri, Sahar M; Eldehna, Wagdy M; Ismail, Nasser S M; Elgazwi, Sara M; Ghabbour, Hazem A; Ahmed, Mahmoud Salama; Halaweish, Fathi T; Abou El Ella, Dalal |
| 120 | 2011 | Optimization of Benzoisothiazole dioxide inhibitory activity of the NS5B polymerase of HCV genotype 4 using ligand-steered homological modeling, reaction-driven scaffold-hopping and Enovo workflow | Mahmoud, Amr Hamed; Abouzid, Khaled ; El Ella, Dalal Abd El Rahman Abou; Hamid Ismail, Mohamed Abdel |
